Patients Why “rare disease” is a regulatory label, not a patient real... Regulators define a rare disease by how many people have it, and the answer depends on who is counting.
Patients From bedside to breakthroughs: Reimagining the human experie... Patients should be involved in the programme design process from the beginning, as co-creators with full influence over the outcome.
Patients Reshaping the future of patient-centric drug development Strategic partnerships, robust quality systems, and manufacturing know-how will support next-generation therapies with patient-centric designs.
Patients Moving from patient centricity to patient partnership The desire for patients to be active partners in research challenges how organisations approach patient engagement.
R&D Parexel: Flawless execution, policy shifts & patient-centric... Parexel's Paul Bridges & Charlotte Moser discuss Europe's biotech sector in the face of an innovation cliff.
Patients Patient engagement drives clinical and commercial success Engagement solutions can tap into long-lasting patient motivations that sustain behaviour.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.